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Abstract
Background: Rift Valley fever virus is an arthropod-borne human and animal pathogen responsible for large outbreaks of
acute and febrile illness throughout Africa and the Arabian Peninsula. Reverse genetics technology has been used to
develop deletion mutants of the virus that lack the NSs and/or NSm virulence genes and have been shown to be stable,
immunogenic and protective against Rift Valley fever virus infection in animals. We assessed the potential for these deletion
mutant viruses to infect and be transmitted by Aedes mosquitoes, which are the principal vectors for maintenance of the
virus in nature and emergence of virus initiating disease outbreaks, and by Culex mosquitoes which are important
amplification vectors.
Methodology and Principal Findings: Aedes aegypti and Culex quinquefasciatus mosquitoes were fed bloodmeals
containing the deletion mutant viruses. Two weeks post-exposure mosquitoes were assayed for infection, dissemination,
and transmission. In Ae. aegypti, infection and transmission rates of the NSs deletion virus were similar to wild type virus
while dissemination rates were significantly reduced. Infection and dissemination rates for the NSm deletion virus were
lower compared to wild type. Virus lacking both NSs and NSm failed to infect Ae. aegypti.I nCx. quinquefasciatus, infection
rates for viruses lacking NSm or both NSs and NSm were lower than for wild type virus.
Conclusions/Significance: In both species, deletion of NSm or both NSs and NSm reduced the infection and transmission
potential of the virus. Deletion of both NSs and NSm resulted in the highest level of attenuation of virus replication. Deletion
of NSm alone was sufficient to nearly abolish infection in Aedes aegypti mosquitoes, indicating an important role for this
protein. The double deleted viruses represent an ideal vaccine profile in terms of environmental containment due to lack of
ability to efficiently infect and be transmitted by mosquitoes.
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Introduction
Rift Valley fever virus (RVFV), a human and animal pathogen
that is endemic in much of Africa, has in recent decades spread to
Saudi Arabia, Madagascar and Yemen and has the potential to
spread to other parts of the world via transport of infected
livestock, humans or mosquitoes or by an act of bioterrorism [1–
6]. An arthropod-borne member of the Phlebovirus genus of the
family Bunyaviridae, RVFV causes significant outbreaks of severe
disease in livestock, including mortality in young animals, fetal
deformities and abortion. RVFV infection in humans can result in
a self-limiting febrile illness or more severe disease such as retinitis,
hepatic necrosis, encephalitis, neurologic deficits or fatal hemor-
rhagic fever [7–9]. The primary maintenance host and source of
RVFV initiating disease outbreaks is considered to be mosquitoes
in the Aedes genus. Mosquitoes in the Culex genus are thought to be
important in amplification of virus activity during outbreaks. The
virus has also been detected in phlebotomine sand flies, Culicoides
midges, and Amblyomma tick species although these infections are
not thought to play an important role in the life cycle of the virus
or in disease outbreak settings [5,10–13]. In laboratory studies,
several North American Aedes and Culex mosquito species have
been shown to be competent vectors of the virus, indicating the
potential for establishment of RVFV transmission cycles in North
America [14–17].
Infection, replication and transmission of an arthropod-borne
virus involve complex interactions between the virus and various
cells/tissues/organs of the vector. Successful transmission requires
that after being ingested in a viremic bloodmeal the virus must
enter the epithelial cells of the midgut, replicate and escape from
the midgut cells into the hemolymph. This is followed by infection
of secondary organs, including the salivary glands, where the virus
www.plosntds.org 1 May 2012 | Volume 6 | Issue 5 | e1639enters the saliva and can then be transmitted to a new host.
Potential barriers in this process have been identified that can
block infection, replication and/or transmission of a virus by the
mosquito [18,19]. These include the midgut infection and escape
barriers and the salivary gland infection and escape barriers. The
presence or absence of these barriers and the degree to which they
are effective appears to be influenced by the genetics of both the
virus and the vector [18].
The RVFV genome is comprised of three segments of single-
stranded, negative sense RNA. The small (S) segment codes for the
structural nucleoprotein (NP) and the nonstructural NSs protein,
the medium (M) segment encodes the two structural glycoproteins,
Gn and Gc, as well as two nonstructural proteins (NSm and NSm-
Gn) and the large (L) segment codes for the viral RNA-dependent
RNA polymerase. The nonstructural NSs and NSm proteins have
been shown to function as virulence factors. The NSs protein has
multiple functions that suppress the mammalian host cell antiviral
response by inhibiting IFN-b gene transcription, promoting
degradation of protein kinase (PKR) and suppressing host
transcription [20–24]. The RVFV NSm protein plays a role in
viral pathogenesis by suppression of virus-induced apoptosis in
infected cells although it has been shown to be dispensable for
efficient virus growth in cell culture [25–27]. To date, little is
known regarding the role of the NSs and NSm proteins in the
RVFV replication cycle and dissemination and transmission in
arthropod vectors.
Historically, a number of different methods have been
employed in development of RVFV vaccines, however due to
drawbacks associated with currently available vaccines including
the necessity for multiple inoculations, abortions/teratologic
effects in some vaccinated animals or risk of reversion to virulent
phenotype, none of the existing vaccines is approved for veterinary
use in North America or Europe [3,28]. More recently, a reverse
genetics methodology has been used to develop recombinant
(rRVF) vaccine candidate viruses which contain complete
deletions of one or both of the RVFV virulence genes NSs and
NSm [29]. These rRVF viruses have been shown to be highly
immunogenic and effective at preventing RVFV-associated
morbidity and mortality [29]. Additionally, these gene deletions
provide the basis for assays to differentiate between vaccinated and
naturally infected animals [30].
The purpose of this study was to determine the effects of NSs
and NSm gene deletions on infection, dissemination and
transmission of these rRVF vaccine candidate viruses in
mosquitoes. Results are presented for each of the three deletion
mutant rRVF viruses and rRVF-wild type evaluated side-by-side
in two mosquito species representing two different genera: Aedes
(Stegomyia) aegypti L. and Culex (Culex) quinquefasciatus (Say).
Materials and Methods
Viruses and Mosquitoes
Construction of the rRVF viruses has been previously described
[25,29,31]. Reverse genetics-generated rRVF-wild type (rRVF-wt)
and three deletion mutant viruses were used in this study (Table 1).
Rescue of rRVF viruses was as previously described [29]. All
rescued viruses were fully sequenced as previously described [32].
Virus nomenclature and titers of the Vero E6-2 passage of the
viruses are listed in Table 1. Growth curves for each rRVF virus
were conducted in Vero E6 cells to determine the optimal virus
growth time for bloodmeal preparation. Cell monolayers were
infected with virus in Dulbecco’s Minimal Essential Medium/2%
fetal bovine serum (FBS) with 100 U/mL penicillin and 100 mg/
mL streptomycin (DMEM) at a multiplicity of infection (m.o.i.) of
0.1 plaque forming unit (PFU) per cell. Following adsorption for
1h ra t3 7 uC cells were washed three times with DMEM and then
maintained in DMEM at 37uC. Samples were removed daily for 5
days and titers were determined by double overlay plaque titration
assay on Vero cells as previously described [33]. Second overlays
were added at 3 days post infection (p.i.) and plaques were counted
on days 4–7 p.i.
Two mosquito species were used in this study. The Aedes aegypti
Rexville D mosquito strain used was an isofemale line derived
from a population of Ae. aegypti collected as larvae in San Juan,
Puerto Rico (Rexville) in 1991 [34]. The Culex quinquefasciatus
Sebring mosquito strain used was originally colonized in Florida in
1998 and has been in colony at the CDC in Fort Collins since
2004 [35]. The species identity of the Cx. quinquefasciatus colony
was verified by examination of genetalia and by HotAce PCR [36–
38]. These species were selected because they are found in Africa,
where the RVFV candidate vaccines being tested will primarily be
used, because of their availability as colonized populations and
because their vector competence for RVFV has been previously
characterized [13,15,16,39].
Oral Infection of Mosquitoes
Multiple blood-feeding experiments were undertaken. Each
experiment utilized freshly prepared virus due to an observed
Table 1. Reverse genetics-generated RVF viruses used in this
study.
Virus Designation Description Titer
1
rRVF-wt wild type 8.3
rRVF-DNSs NSs gene deleted 8.2
rRVF-DNSm NSm gene deleted 7.0
rRVF-DNSs-DNSm NSs and NSm genes deleted 8.0
1Vero E6 cell, passage 2 titer expressed as log10 PFU/ml.
doi:10.1371/journal.pntd.0001639.t001
Author Summary
Rift Valley fever virus is transmitted mainly by mosquitoes
and causes disease in humans and animals throughout
Africa and the Arabian Peninsula. The impact of disease is
large in terms of human illness and mortality, and
economic impact on the livestock industry. For these
reasons, and because there is a risk of this virus spreading
to Europe and North America, it is important to develop a
vaccine that is stable, safe and effective in preventing
infection. Potential vaccine viruses have been developed
through deletion of two genes (NSs and NSm) affecting
virus virulence. Because this virus is normally transmitted
by mosquitoes we must determine the effects of the
deletions in these vaccine viruses on their ability to infect
and be transmitted by mosquitoes. An optimal vaccine
virus would not infect or be transmitted. The viruses were
tested in two mosquito species: Aedes aegypti and Culex
quinquefasciatus. Deletion of the NSm gene reduced
infection of Ae. aegypti mosquitoes indicating a role for
the NSm protein in mosquito infection. The virus with
deletion of both NSs and NSm genes was the best vaccine
candidate since it did not infect Ae. aegypti and showed
reduced infection and transmission rates in Cx. quinque-
fasciatus.
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bloodmeals: in a separate experiment we observed only a 10%
(n=19) rate of infection in Ae. aegypti mosquitoes fed a bloodmeal
containing frozen rRVF-wt virus compared to 63% (n=32) with
freshly harvested virus.
For each experiment, adult 7- to 10-day old mosquitoes were
placed in pint cartons (approx. 50–100 mosquitoes per carton) and
starved for 24 hours prior to feeding. Artificial virus-laden
bloodmeals were prepared using fresh virus grown in Vero E6
cells as described above. Virus was harvested 2–3 days after
infection depending on growth curve results for each virus (data
not shown). Infected cell culture supernatant was clarified by
centrifugation at 10 K rpm, 4uC for 10 min. Defibrinated chicken
blood (Colorado Serum Co., Denver, CO) was washed 3 times
with 1 volume of ice-cold phosphate buffered saline and
centrifuged at 3 K rpm, 4uC for 3 min after each wash. Two
parts clarified virus were mixed with 2 parts washed blood and 1
part FBS/10% sucrose. The bloodmeal was heated to 37uC and
offered to mosquitoes using cotton balls that were soaked in the
bloodmeal and applied to the mesh top of the mosquito cartons.
Mosquitoes were allowed to feed for 30 min at 28uC/95%
humidity after which the bloodmeal was removed. Fully engorged
mosquitoes were collected, double-caged and held for 14 days at
28uC/95% humidity with 5% sugar water. Three engorged
mosquitoes were immediately removed for each virus and titrated
to determine the amount of virus ingested (input virus titer).
Mosquito Testing
Twenty-five to fifty mosquitoes from each virus group were
tested for virus transmission at 14 days post exposure by collection
of saliva as previously described [40]. Briefly, specimens were
anesthetized by chilling at 220uC for 1 min, then, inside a glove
box, wings were removed and the proboscis of each specimen was
inserted into a capillary tube containing 5 mL immersion oil and
saliva collected for 20 min. The tip of each capillary tube was
clipped off into a microfuge tube containing 250 mL DMEM/10%
FBS, tubes were centrifuged 5 min at 5000 rpm at 4uC to draw
the oil out of the capillary tube and titers were determined as
described above [33]. Observation of one or more viral plaques
was considered a positive result. Following saliva collection,
individual mosquito bodies were stored at 280uC. Additional day
14 mosquitoes were stored at 280uC and were tested only for
dissemination and/or infection status. Mosquitoes were subse-
quently tested for virus dissemination by head squash and
immunofluorescence assay (IFA) as previously described, using
mouse-anti RVFV strain ZH501 hyperimmune ascitic fluid
diluted 1:2500 as the primary antibody and goat-anti-mouse
IgG-Alexa488 (Invitrogen, Baltimore, MD) diluted 1:2000 as the
secondary antibody conjugate [40]. Observation of specific
fluorescence as compared to uninfected controls was considered
a positive result. The infection status of mosquitoes was
determined by trituration of bodies in 2 mL conical microcen-
trifuge tubes with 1 mL BA-1 medium (16 medium 199 with
Earle’s salts, 1% bovine albumin, 100 U/mL penicillin, 100 mg/
mL streptomycin, and 1 mL/mL amphotericin B) and one copper
BB per tube using a Qiagen Tissuelyser (Qiagen, Valencia, CA).
Triturated mosquito preparations were clarified by centrifugation
at 9 K rpm/4uC for 10 min followed by plaque titration of the
clarified supernatant on Vero cells as above.
Virus was isolated and sequenced from selected mosquitoes at
14 days post-exposure as follows. Viral RNA was extracted either
from triturated mosquito supernatant or from a Vero cell
amplification of mosquito supernatant (25 mL mosquito superna-
tant grown 3 days in a T25 flask of Vero cells) using the QIAamp
viral RNA kit (Qiagen). RT-PCR was performed using the Titan
One-Step RT-PCR kit (Roche, Indianapolis, IN). Products were
agarose gel purified and sequenced using the BigDye Terminator
v3.1 Ready Reaction Cycle Sequencing mix (Applied Biosystems,
Foster City, CA). Reactions were purified using the BigDye
Xterminator Purification kit (Applied Biosystems) and analyzed on
an ABI 3130 Genetic Analyzer (Applied Biosystems).
Statistical Analysis
Linear regression methods were used to compare (log10-
transformed) titers among the virus constructs, while logistic
regression was used to compare their infection, dissemination, and
transmission rates. Wald 95% confidence intervals were computed
for parameters of interest, and likelihood ratio tests were used to
compare models. Because the data have cases for which all
individuals in a virus test group were either negative or positive, we
use Firth’s penalized likelihood adjustment to the estimating score
equations, as detailed in Heinze and Schemper (2002) and Heinze
and Puhr (2010) and implemented in R (www.r-project.org) in the
package logistf [41,42]. All analyses were conducted in R version
2.11.1 (www.r-project.org). Confidence intervals for the differences
of virus effects were adjusted for multiple comparisons in both
normal and logistic models using the methods described in
Hothorn et al. (2008) [43].
Due to the necessity of using freshly grown, and therefore
untitrated, virus in the oral mosquito feeds, the standard regression
methods for the body titers and infection rates were augmented to
adjust for the unknown amount of virus taken up during the
feedings by using the information collected from the mosquitoes
fed concurrently and stored just after feeding (input virus titer).
This was necessary because the titers for the different viruses
varied between each virus stock preparation. Although significant
results were found, we cannot rule out that this variation in the
virus titers may have affected the results in a manner that cannot
be accounted for by the statistical analysis. To summarize the
approach, we treated the unknown amount of virus taken up by
the test mosquitoes as missing data, represented in the linear
models as a simple, continuous random effect and in the logistic
models as a continuous, random offset. We then used the
estimated, predictive normal distributions of the concurrently fed
individuals’ input virus log10-titer measurements from the
corresponding virus to impute values for the unknown virus
uptake of the test individuals. For each individual we generated
100 such imputations, fit regression models to each of these
‘‘completed’’ datasets, and averaged the parameters from the
resulting model fits. Statistical comparisons and tests, confidence
intervals and p-values incorporated both the modeling uncertainty
and the imputation uncertainty; see Little and Ruben (2002) for
details related to analysis of missing data and incorporation of
imputation error [44].
For the dissemination and transmission rates, Fisher’s exact tests
were used to test for an overall difference, and pairwise
comparisons among viruses were made using score confidence
intervals for the differences. The Bonferroni adjustment was used
to account for the multiple comparisons.
Results
Viral RNA from 25 randomly selected infected mosquitoes
representing both species and all four viruses was sequenced and
compared to the nucleotide sequence of the bloodmeal viruses; no
differences were observed. Results from Ae. aegypti and Cx.
quinquefasciatus experiments are listed in Tables 2 and 3,
respectively. Dissemination rates in these tables are calculated in
RVFV Lacking NSs and/or NSm Genes in Mosquitoes
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www.plosntds.org 5 May 2012 | Volume 6 | Issue 5 | e1639two ways: 1) De=number positive divided by number exposed to
virus and 2) Di=number positive divided by number infected.
Similarly, transmission rates are shown as 1) Te=number positive
divided by number exposed to virus and 2) Td=number positive
divided by number disseminated. Where data from two separate
experiments are presented in Tables 2 and 3 we have combined
and summarized the results in the text below as noted.
Ae. aegypti
Replication of the rRVF-wt and deletion mutant viruses in Ae.
aegypti mosquitoes is summarized in Table 2 with statistical analysis
results data available in Table S1. The infection rate observed for
the rRVF-DNSs virus (32/36, 88.9%) did not differ significantly
from that observed for the rRVF-wt virus (20/32, 62.5%),
although the average body titer at 14 days post-exposure for
individuals infected with rRVF-DNSs (3.7 log10 PFU/mL) was
significantly lower than for rRVF-wt (5.4 log10 PFU/mL) (P,0.01,
data not shown). Dissemination rates for the rRVF-DNSs virus
(De, from two experiments combined=33/86, 38.4%, and
Di=16/32, 50%) were significantly lower than for rRVF-wt (De
combined=44/63, 69.8% and Di=18/20, 90%), while transmis-
sion rates for rRVF-DNSs (Te=12/36, 33.3% and Td=12/16,
75%) and rRVF-wt (Te=15/32, 46.9% and Td=15/18, 83.3%)
did not differ significantly. RVFV antigen was found to be
similarly distributed throughout head tissues by IFA testing of
individuals with disseminated rRVF-wt and rRVF-DNSs infections
(data not shown).
The Ae. aegypti infection rate for the rRVF-DNSm virus (5/129,
3.9%, combined) was significantly less than for rRVF-wt (20/32,
62.5%). The rRVF-DNSm infection rate in experiment 1 (5/45,
11.1%) was higher than that of experiment 2 (0/84, 0%), most
likely due to the higher experiment 1 bloodmeal titer, although
when calculated individually both rates were significantly less than
that of rRVF-wt. The average body titer of rRVF-DNSm-infected
mosquitoes (1.9 log10 PFU/mL) at 14 days post-exposure was
significantly less than that of mosquitoes infected with rRVF-wt
(5.4 log10 PFU/mL) (P,0.01, data not shown). The dissemination
rates for rRVF-DNSm (De combined=1/129, 0.8% and Di=1/5,
20%) were significantly less than rRVF-wt (De combined=44/63,
69.8% and Di=18/20, 90%). The transmission rate for rRVF-
DNSm (Te combined=1/95, 1.1%,) was significantly less than
that of rRVF-wt (Te=15/32, 46.9%) when calculated as Te
(number positive/number exposed); when calculated as Ti
(number positive/number disseminated) the transmission rate
did not differ significantly from rRVF-wt. Out of 129 Ae. aegypti
mosquitoes that fed on a bloodmeal containing the rRVF-DNSm
virus, five became infected and one developed a disseminated
infection; this individual was also found to be transmission-
positive. The distribution of RVFV antigen in head tissues of this
individual did not appear to differ from that of rRVF-wt (data not
shown). Full length sequencing of virus isolated from this
individual revealed no genetic differences compared to the virus
in the blood meal.
None of the 75 Ae. aegypti mosquitoes exposed to rRVF-DNSs-
DNSm were found to be infection-, dissemination- or transmission-
positive.
Cx. quinquefasciatus
Replication of the rRVF-wt and deletion mutant viruses in Cx.
quinquefasciatus mosquitoes is summarized in Table 3 with statistical
analysis data presented in Table S2. Similarly high infection rates
were observed for rRVF-wt (57/60, 95%, combined) and rRVF-
DNSs (33/35, 94.3%), while significantly lower rates were
observed for the constructs containing the NSm deletion [rRVF-
DNSm (4/35, 11.4%) and rRVF-DNSs-DNSm (33/50, 66%)].
There were no significant differences in the dissemination or
transmission rates of the rRVF-DNSs or rRVF-DNSs-DNSm
viruses compared to the rRVF-wt virus. When calculated as De
(number positive/number exposed), the dissemination rate for the
rRVF-DNSm virus (De=1/119, 0.8%) was significantly less than
that of rRVF-wt (De combined=17/156, 10.9%), however, the
dissemination rate calculated as Di (number positive/number
infected) was not significantly different and there were no
significant differences in transmission rates between these viruses.
IFA testing demonstrated the presence of RVFV antigen
distributed throughout head tissues from Cx. quinquefasciatus
individuals with a disseminated infection; no qualitative differences
were observed between tissues infected with the deletion mutant
viruses and rRVF-wt (data not shown). Average body titers of
individuals with disseminated infections ranged from 4.4–6.1 log10
PFU/mL, while titers in individuals with undisseminated infec-
tions ranged from 1.0–4.3 log10PFU/mL. These values are similar
to those reported for Cx. pipiens mosquitoes by Turell et al. [14].
Discussion
We report the in vivo infection, dissemination and transmission
characteristics of several recombinant RVF viruses lacking the
entire coding regions of the NSs and/or the NSm genes and
demonstrate the critical role of the NSm gene for infection and
transmission in two mosquito species that exhibit different
capacities for transmitting RVFV. Ae. aegypti has been shown to
be a moderately competent vector of RVFV, although it has not
been shown to be a vector in nature [13,39]. Cx. quinquefasciatus is a
potential vector of RVFV in nature, although laboratory studies
have shown it to be a less efficient vector than Ae. aegypti.
[5,13,39,45]. These species were selected based on this difference
in vector competence, because both are found in Africa where the
candidate vaccine viruses tested here will primarily be used and
because both have been colonized for use in laboratory
investigations.
Observed rates of dissemination of rRVF-wt in Ae. aegypti were
much greater than those in Cx. quinquefasciatus mosquitoes in our
study. At 14 days post-exposure, 90% of rRVF-wt-infected Ae.
aegypti individuals had titers greater than the average input virus
titer. This is in marked contrast to the Cx. quinquefasciatus
mosquitoes, where at 14 days post-exposure only 10.5% had a
rise in body titer that was greater than the input virus titer and
35% of individuals with detectable virus at 14 days post-exposure
had body titers #2.0 log10 PFU/mL. Additionally, dissemination
rates for rRVF-wt in Cx. quinquefasciatus were low (#16.7%)
(Table 3). These observations support the hypothesis that a midgut
infection and/or midgut escape barrier is responsible for the lower
vector competence of this species compared to Aedes species for
RVFV [13,15,16].
The recombinant viruses tested comprised three groups: those
with a deletion of the NSs gene from the S segment of the virus,
those with a deletion of the NSm gene from the M segment, and
those with both the NSs and NSm genes deleted. Recombinant
RVFV lacking the NSs gene has been shown to maintain the
virulence and growth characteristics of the wild type virus in
mammalian cell culture, and in vivo testing demonstrated it to be
highly attenuated, immunogenic and protective against challenge
with wild type virus making it a potential vaccine candidate [29].
RVFV Clone 13, an attenuated clone containing a deletion of
70% of the NSs gene, has been shown to exhibit a lower infection
rate in Cx. quinquefasciatus mosquitoes compared to wild type
RVFV ZH548, while no difference was observed in Ae. vexans
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www.plosntds.org 6 May 2012 | Volume 6 | Issue 5 | e1639mosquito infection rates [46]. In our study, deletion of the NSs
gene alone did not significantly affect rates of infection or
transmission compared to rRVF-wt in either Ae. aegypti or Cx.
quinquefasciatus mosquitoes although the dissemination rate for
rRVF-DNSs was significantly lower than rRVF-wt in Ae. aegypti.
Recombinant RVFV lacking the NSm gene exhibits efficient
replication in cell culture and although in vivo studies have
demonstrated this mutant virus to be highly immunogenic it is
only partially attenuated relative to the wild type virus, retaining
the ability to cause lethal hepatic or neurologic disease in a
minority of infected animals [29,31]. In the current study, deletion
of the NSm gene significantly reduced infection rates in both
mosquito species tested. In Ae. aegypti mosquitoes, dissemination
and transmission rates were also significantly reduced suggesting
an important role for the NSm proteins in this species.
Given the characteristics of RVFV mutant viruses individually
lacking the NSs or NSm genes, Bird, et al., have hypothesized that
combining these deletions in a single mutant virus would generate
a stable, attenuated, immunogenic vaccine virus [29]. Results of in
vitro and in vivo studies characterizing the double NSs and NSm
deleted recombinant virus suggest that this hypothesis is correct
[29]. The double deletion virus grows efficiently in cell culture and
in animals this virus is highly attenuated, immunogenic and
confers protective immunity from wild type virus challenge [29].
We observed that deletion of the NSs and NSm genes in
combination affected RVFV growth differently in the two
mosquito species tested. Deletion of both the NSs and NSm genes
had a pronounced effect in Ae. aegypti mosquitoes; none of the Ae.
aegypti that ingested a bloodmeal containing the rRVF-DNSs-
DNSm virus became infected (n=75). In contrast, infection with
rRVF-DNSs-DNSm of the less competent vector, Cx. quinquefascia-
tus, was significantly reduced compared to rRVF-wt, although to a
lesser degree than in Ae. aegypti, and no significant differences in
dissemination or transmission rates were observed. It was
apparent, however, that in Cx. quinquefasciatus the additional
deletion of the NSm gene reduced the infection rate of the double
deletion virus, rRVF-DNSs-DNSm, (33/50, 66.0%) compared to
the rRVF-DNSs single deletion virus (33/35, 94.3%) (Table 3).
The Cx. quinquefasciatus rRVF-DNSs-DNSm infection rate was
higher than the rRVF-DNSm rate, however this is most likely due
to the higher titer of the rRVF-DNSs-DNSm bloodmeal.
In vivo studies by Bird, et al., showed no detectable post-
vaccination viremia in n=20 rats [29] and more recently in n=42
sheep inoculated with the double deletion virus [47]. These results,
coupled with our observation that in the more competent Ae.
aegypti vector a bloodmeal titer of 7.0 log10 PFU/mL did not result
in infection of mosquitoes with this virus, suggest an extremely low
likelihood that mosquitoes could acquire an infectious dose of virus
from feeding on a vaccinated animal. This is important since, due
to the segmented nature of the RVFV genome, the potential exists
for reassortment and therefore reversion of mutations in a
mosquito that has acquired both vaccine and wild type strains of
the virus from feeding on multiple hosts [48]. The deletion of
genes from multiple segments of the virus genome in the rRVF-
DNSs-DNSm vaccine candidate virus adds an additional safeguard
against this mechanism of reassortment-driven reversion to wild
type.
The results of this study demonstrate that deletion of the RVFV
NSm gene alone or in combination with the NSs gene significantly
affected the replication kinetics of the virus in the mosquito species
tested, particularly in Ae. aegypti. The combined deletion of both
gene regions resulted in the greatest attenuation of RVFV
replication in these mosquitoes, suggesting that the rRVF-DNSs-
DNsm virus is an acceptable vaccine candidate with little
possibility of environmental contamination due to the lack of
efficient infection and transmission in mosquitoes.
The RVFV NSm has been demonstrated to function as a
suppressor of virus-induced apoptosis in mammalian cells in
culture although a similar role has not been demonstrated in
arthropod cells [26]. However, NSm has also been shown to be
non-essential for replication in cultured mammalian cells suggest-
ing it may have a more significant function in the infection of
insect vectors involved in amplification and transmission of RVFV
in nature [25,27]. In our study, the reduced infection rates
observed in both Ae. aegypti and Cx. quinquefasciatus species and the
diminished whole body virus titers of infected Ae. aegypti
mosquitoes suggest a possible role for NSm in modulation of a
mosquito midgut infection barrier. Additionally, the reduction in
rates of dissemination and transmission in Ae. aegypti indicate that
NSm may also function as a suppressor of a midgut escape barrier.
Although the mechanisms of these barriers are not understood, it is
apparent that the genetic traits of the virus as well as those of the
mosquito host species influence the infection, dissemination and
transmission of arboviruses [18]. The rRVF-DNSm deletion
mutant will be a valuable tool in future studies to elucidate the
mechanisms of RVFV infection and transmission in mosquito
vectors.
Supporting Information
Table S1 Aedes aegypti statistical analysis results for
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